Vectura has confirmed that it has won the US GlaxoSmithKline (GSK) patent litigation trial and has been awarded $89.7million in damages by the trial jury.
A $289 million award against Monsanto in a case linking its Roundup week killer to terminal cancer in a former school groundskeeper may lead to similar judgments against the company, according to the man's lawyers.